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TO THE EDITOR
Exposure of human skin to UVB-irradia-
tion results in epidermal hyperplasia,
erythema, vascular hyperpermeability,
and edema formation. Previous studies
have revealed that pronounced
angiogenesis is induced by acute UVB-
irradiation, and that several angiogen-
esis factors – including vascular
endothelial growth factor (VEGF)-A, basic
fibroblast growth factor and interleukin
8 – are upregulated after acute UVB-
irradiation (Kramer et al., 1993; Strick-
land et al., 1997; Bielenberg et al.,
1998). Recently, we have shown that
targeted overexpression of VEGF-A en-
hances sensitivity to UVB-induced cu-
taneous photodamage (Hirakawa et al.,
2005), whereas transgenic overexpres-
sion of the angiogenesis inhibitor
thrombospondin-1 in the epidermis
completely prevented UVB-induced
damage (Yano et al., 2002). Together,
these findings indicate that the cuta-
neous blood vasculature plays a critical
role in the mediation of photodamage.
In contrast, the role of lymphatic vessels
in the response to UVB-irradiation has
remained unknown.
The lymphatic vascular system is
composed of a dense network of thin-
walled capillaries that drain protein-
rich lymph from the extracellular
spaces. Its major functions are the
maintenance of tissue fluid homeostasis
and the mediation of the afferent
immune response (Witte et al., 2001;
Oliver and Detmar, 2002). Studies of
the role of lymphatic vessels in disease
have been hampered by the lack of
specific markers that distinguish blood
and lymphatic vessels, and by the lack
of knowledge about specific growth
factors for lymphatic endothelium.
Recent studies have identified VEGF-C
and VEGF-D as specific lymphangio-
genesis factors, acting via activation of
the VEGF receptor-3 (VEGFR-3), which
is specifically expressed on lymphatic
endothelial cells (Jussila and Alitalo,
2002). Transgenic overexpression of
VEGF-C in the epidermis promotes
lymphatic vessel formation in the skin
(Jeltsch et al., 1997), whereas targeted
overexpression of a soluble VEGFR-3 –
which prevents VEGF-C and VEGF-D
from reaching their receptor on lym-
phatic endothelium – in the epidermis
of transgenic mice leads to lymphede-
ma (Makinen et al., 2001). In fact,
missense mutations of VEGFR-3 have
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Figure 1. Systemic inhibition of VEGFR-3 prolongs UVB-induced edema formation and inflammation.
VEGF transgenic mice were exposed to a single dose of 200 mJ/cm2 of UVB irradiation. (a) Ear swelling is
expressed as the increase (D) in thickness (in mm) over pre-irradiation values. Whereas no differences
between anti-VEGFR-3-treated (’) and control-IgG-treated (~) mice were observed during the first 4
days after irradiation, the ear thickness of the control-treated mice went back to normal levels after day 6,
but anti-VEGFR-3-treated mice showed prolonged ear swelling until day 9 (*Po0.05 at days 6 and 9;
**Po0.01 at days 7 and 8). Data are expressed as mean7SE (n¼ 5). (b and c) Hematoxylin–eosin stains at
day 9 revealed that the ear skin of (c) anti-VEGFR-3-treated mice retained characteristics of acute
photodamage, including epidermal hyperplasia, marked dermal edema, vessel dilation, and inflamma-
tory cell infiltration in the dermis, whereas the findings in (b) control-IgG-treated mice were similar to
non-UVB-irradiated mice. (d and e) Immunohistochemistry for CD11b (red) revealed increased
macrophage infiltration in the dermis of (e) VFGFR-3-treated mice as compared to (d) mice treated with
control-IgG. (b–e) Bars¼100 mm.
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been found in several families affected
by congenital lymphedema (Karkkainen
et al., 2000). Moreover, several specific
lymphatic markers have been recently
identified, including the homeobox
transcription factor Prox1, the lympha-
tic endothelial hyaluronan receptor
(LYVE-1), and the mucin-type trans-
membrane glycoprotein podoplanin
(Oliver and Detmar, 2002). As one of
the major functions of lymphatic vessels
is drainage of tissue fluid from normal
and inflamed tissues (Kunstfeld et al.,
2004), we hypothesized that they might
also play a functional role in the
cutaneous response to UVB-induced
skin damage.
Previously established transgenic
mice which overexpress VEGF-A under
the control of the K14 promoter (Det-
mar et al., 1998; Hirakawa et al., 2005)
(males, 7 weeks old) were treated
intraperitoneally with 700 mg of a
blocking antibody against mouse
VEGFR-3 (kindly provided by Dr Bronek
Pytowski, Imclone Systems Inc., New
York, NY; n¼5) or with 700mg of
control rat IgG (R&D Systems, Minnea-
polis, MN) every other day (five injec-
tions total). One day after the first
antibody injection, mice were exposed
to a single dose of 200 mJ/cm2 UVB
(day 0) and ear thickness was measured
daily until day 9 after UVB-irradiation.
All experiments were approved by the
Massachusetts General Hospital Sub-
committee on Research Animal Care.
UVB-irradiation induced inflammation
and edema of the ear skin as early as
1 day after irradiation (Figure 1a), with
a maximum ear swelling observed after
4 days (Figure 1a). Whereas no differ-
ences between the treatment groups
were observed during the first 4 days
after irradiation, the ear thickness of the
control-IgG-treated mice went back to
normal levels after day 6, whereas anti-
VEGFR-3-treated mice showed pro-
longed ear swelling until day 9
(Po0.05 at days 6 and 9; Po0.01 at
days 7 and 8). As VEGF-A does not bind
to VEGFR-3, the effect observed was
specifically due to inhibition of lym-
phatic function.
Hematoxylin–eosin stains of frozen
sections at day 9 after the UVB-irradia-
tion revealed that the ear skin of anti-
VEGFR-3-treated mice still displayed
the characteristic features of acute
photodamage, including epidermal hy-
perplasia, marked dermal edema, vas-
cular dilation, and inflammatory cell
infiltration in the dermis (Figure 1c). In
contrast, the ear skin of control-IgG-
treated mice already resembled histo-
logically the non-UVB-irradiated skin
(Figure 1b). Immunohistochemistry
using an antibody against mouse
CD11b (BD Pharmingen, San Diego,
CA) revealed increased macrophage
infiltration in the dermis of anti-
VFGFR-3-treated mice, as compared
with mice treated with control-IgG
(Figure 1d and e). These surprising
findings indicate that the enlarged
lymphatic vessels in anti-VEGFR-3-trea-
ted mice were functionally impaired
with regard to fluid and cell transport.
To elucidate whether inhibition of
the VEGF-C/VEGFR-3 pathway pre-
vented lymphatic vessel activation, we
next stained ear skin sections – by
immunofluorescence – with antibodies
against the lymphatic vessel-specific
marker LYVE-1 (kindly provided by Dr
D. Jackson, Oxford, UK) and against
the panvascular marker CD31 (BD
Pharmingen) at day 9 after the UVB-
irradiation. We found that LYVE-1-
positive lymphatic vessels were greatly
enlarged in the ear skin of anti-VEGFR-
3-treated mice (Figure 2b), whereas
lymphatic vessels in mice treated with
control-IgG were collapsed and were
indistinguishable from lymphatic ves-
sels in non-irradiated ear skin (Figure
2a). In contrast, CD31-positive/LYVE-1-
negative blood vessels were compar-
able in both treatment groups (Figure 2a
and b). Morphometric analysis, using
the IP-LAB software (Scanalytics, Fair-
fax, VA) as described (Kajiya et al.,
2005), revealed that the average skin
area covered by lymphatic vessels was
significantly larger in anti-VEGFR-3-
treated mice than in control-IgG-treated
mice (Po0.05) (Figure 2c). Moreover,
the average size of lymphatic vessels
was significantly larger in the ear skin of
anti-VEGFR-3-treated mice than in con-
trol-treated mice (Po0.001) (Figure 2d).
The number of lymphatic vessels was
similar in both groups (Figure 2e).
Future studies are needed to evaluate
the distinct effects of specific blockade
of VEGFR-2 versus VEGFR-3 on
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Figure 2. Prolonged enlargement of lymphatic vessels in anti-VEGFR-3-treated mice. (a and b)
Differential immunofluorescence stains for LYVE-1 (red) and CD31 (green) revealed that LYVE-1-positive
lymphatic vessels were still enlarged in the ears of (b) VEGFR-3-treated mice at day 9 after UVB
irradiation, but not in control-IgG-treated mice (a). CD31-positive/LYVE-1-negative blood vessels were
comparable in both groups. Bars¼100 mm. (c–e) Morphometric analyses at day 9 after UVB irradiation
showed that the area covered by lymphatic vessels (c; *Po0.05) and the average size of lymphatic vessels
(d; ***Po0.001) were significantly larger in the ears of anti-VEGFR-3 antibody-treated mice than in mice
treated with control-IgG. (e) No significant differences of the number of lymphatic vessels were found
between the two groups.
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lymphatic function and UVB-induced
cutaneous photodamage in wild-type
mice.
Our results provide the first evidence
that the lymphatic vascular system
plays a functional role in the cutaneous
response to UVB damage. Our findings
that inhibition of lymphatic function via
blockade of VEGFR-3 prolonged UVB-
induced edema formation and inflam-
mation indicate that promotion of
lymphatic function might represent a
new strategy to reduce or prevent UVB-
induced skin damage.
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